JPS6230794A - Production of concentrated aqueous solution of glycyrrhizin - Google Patents

Production of concentrated aqueous solution of glycyrrhizin

Info

Publication number
JPS6230794A
JPS6230794A JP16978385A JP16978385A JPS6230794A JP S6230794 A JPS6230794 A JP S6230794A JP 16978385 A JP16978385 A JP 16978385A JP 16978385 A JP16978385 A JP 16978385A JP S6230794 A JPS6230794 A JP S6230794A
Authority
JP
Japan
Prior art keywords
glycyrrhizin
aqueous solution
concentrated aqueous
production
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP16978385A
Other languages
Japanese (ja)
Inventor
Naohisa Kinoshita
尚久 木下
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MOHAN YAKUHIN KENKYUSHO KK
Original Assignee
MOHAN YAKUHIN KENKYUSHO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MOHAN YAKUHIN KENKYUSHO KK filed Critical MOHAN YAKUHIN KENKYUSHO KK
Priority to JP16978385A priority Critical patent/JPS6230794A/en
Publication of JPS6230794A publication Critical patent/JPS6230794A/en
Pending legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Abstract] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 本発明は室温で、医薬として有用な水難溶性のグリチル
リチンおよびそのモノ塩の濃厚水溶液を製造する方法に
関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing a concentrated aqueous solution of sparingly water-soluble glycyrrhizin and its monosalt useful as a pharmaceutical at room temperature.

グリチルリチンは強力な抗アレルギー作用、抗炎症作用
、慢性肝疾患における肝機能異常の改善作用を有する有
用な物質であることは周知であるグリチルリチンおよび
そのモノ塩は室温では水に溶は難く、また仮りに高温で
溶解した場合、温度の低下と共にそれらがゲル状に析出
する性質を有する。
Glycyrrhizin is well known to be a useful substance that has strong anti-allergic and anti-inflammatory effects, as well as the ability to improve liver function abnormalities in chronic liver diseases. Glycyrrhizin and its monosalts are difficult to dissolve in water at room temperature, and When dissolved at high temperatures, they tend to precipitate into a gel as the temperature decreases.

従って、これらの水溶液を製造する場合、適当量のアル
カリの存在下に、例えば40〜50℃に加温し、溶解し
ているのが実情である。
Therefore, when producing these aqueous solutions, the actual situation is that they are heated to, for example, 40 to 50°C, and dissolved in the presence of an appropriate amount of alkali.

しかし、ときに原料によっては不純物として微量に含ま
れるフラボノイド系色素のため、溶液が淡黄色に着色す
ることがある。
However, depending on the raw material, trace amounts of flavonoid pigments may be present as impurities, which may cause the solution to be colored pale yellow.

他方グリチルリチンのジ塩およびトリ塩は水に可溶性で
あるが純度および着色の点で問題があるため、主に食品
添加物および化粧品に使用され、注射液のように高純度
を要求されるものの原料としては使用されない。
On the other hand, di- and tri-salts of glycyrrhizin are soluble in water but have problems with purity and coloring, so they are mainly used as food additives and cosmetics, and are used as raw materials for products that require high purity such as injections. It is not used as.

そこで本発明者は室温下でグリチルリチンまたはその塩
を高濃度に溶解する方法について鋭意研が得られること
、更に特筆すべきことはクレアチニンの飽和溶液に過量
の固体クレアチニンを懸濁させておき、これにグリチル
リチンまたはそのモノ塩の大量を加えるときはクレアチ
ニンの結晶が消失すると共に予想以上のグリチルリチン
まだはそのモノ塩が溶解することを見出したことである
なお、以上のようにして得られた溶液は所望により水で
希釈することにより、医薬として現に使用されている濃
度、即ち0.1〜2%に何の障害もなく、できることを
見出し本発明を完成するに主液の製造法である。
Therefore, the present inventor has made extensive research into a method for dissolving glycyrrhizin or its salts at high concentrations at room temperature, and what is more noteworthy is that an excess amount of solid creatinine is suspended in a saturated solution of creatinine. It was discovered that when a large amount of glycyrrhizin or its monosalt was added to the solution, the creatinine crystals disappeared and more glycyrrhizin than expected was still dissolved in the monosalt. It was discovered that by diluting with water if desired, the concentration currently used as a medicine, that is, 0.1 to 2%, could be achieved without any problems, and the present invention was completed based on a method for producing the main liquid.

本発明で使用されるグリチルリチンのモノ塩としては例
えば、アンモニウム塩、ナトリウム塩、カリウム塩があ
げられる。
Examples of the monosalt of glycyrrhizin used in the present invention include ammonium salt, sodium salt, and potassium salt.

本発明に従ってグリチルリチンまたはそのモノ塩の濃厚
水溶液を製造するには、先ずクレアチニンの殆ど飽和に
近い溶液(クレアチニン含量約7%以上)を作り、これ
(Cグリチルリチンまたはそのモノ塩を室温(1〜30
し)内の任意の温度で、かくはん下に少量ずつ添加する
。添加後、通常1〜8時間かくはんを続けると、澄明な
さらさらしたグリチルリチンまたはそのモノ塩の濃厚溶
液が得られる。
To produce a concentrated aqueous solution of glycyrrhizin or its monosalt according to the present invention, first a nearly saturated solution of creatinine (creatinine content of about 7% or more) is prepared,
Add it little by little while stirring at any temperature within After addition, stirring is generally continued for 1 to 8 hours to obtain a clear, free-flowing, concentrated solution of glycyrrhizin or its monosalt.

かくして得られる溶液のPHは通常5.0〜5.8の範
囲内にあるので、必要に応じ、これを例えば水酸化ナト
リウム、水酸化カリウム等の水酸化アルカリ、炭酸ナト
リウム、炭酸水素ナトリウム等の炭酸アルカリ等のPH
調整剤でPRを6.0〜7.0とした後、所望の濃度に
なるように水で希釈すればよい。
Since the pH of the solution obtained in this way is usually within the range of 5.0 to 5.8, it may be treated with an alkali hydroxide such as sodium hydroxide or potassium hydroxide, sodium carbonate, sodium bicarbonate, etc., if necessary. PH of alkali carbonate, etc.
After setting the PR to 6.0 to 7.0 with a regulator, it may be diluted with water to a desired concentration.

本発明のグリチルリチンまたはそのモノ塩の、)原水溶
液は、例えばこれをグリチルリチンとしての含量が0.
2 %になるように水で希釈し、次いでこれにL−シス
ティンおよびグリシンのそれぞれを0.1%、2.0%
になるように添加すれば、抗アレルギー・肝臓障害用注
射薬とすることができるなどグリチルリチン含有液剤の
原料として有用である。
For example, the raw aqueous solution of glycyrrhizin or its monosalt of the present invention may have a glycyrrhizin content of 0.
Dilute with water to a concentration of 2%, then add 0.1% and 2.0% of L-cysteine and glycine, respectively.
If added in such a manner, it is useful as a raw material for glycyrrhizin-containing liquid preparations, such as antiallergic injections and liver damage injections.

以下、実施例により本発明を具体的に説明する。Hereinafter, the present invention will be specifically explained with reference to Examples.

実施例1 クレアチニン101を水100dにかくはん下に溶解し
、これに室温(2(1)でグリチルリチン202を少し
ずつ加え約2時間かくはんを続けると、完全に澄明なさ
らさらしたグリチルリチンの20%濃厚溶液(’l’H
5,2)が得られる。
Example 1 Creatinine 101 was dissolved in 100 d of water with stirring, and glycyrrhizin 202 was added little by little at room temperature (2(1)) and stirring was continued for about 2 hours, resulting in a completely clear and free-flowing 20% concentrated solution of glycyrrhizin. ('l'H
5,2) is obtained.

この溶液はIN水酸化ナトリウムでPHを6.7に調整
した後、水で10tになるように希釈すると0.2%グ
リチルリチン水溶液(PH6,8)となる実施例2 実施例1におけるグリチルリチンの代りにモノアンモニ
ウム塩20.49  を用い、同様の方法によりグリチ
ルリチンとして20ヲ≦のグリチルリチン酸アンモニウ
ム塩の濃厚溶液(PH5,62)を得たこの溶液はIN
水酸化ナトリウムでPHを6.7に調整した後、水で1
otになるように希釈して、グリチルリチンとして0.
25’≦の水溶液(PH6,8)を得た。
The pH of this solution was adjusted to 6.7 with IN sodium hydroxide, and then diluted to 10 t with water, resulting in a 0.2% glycyrrhizin aqueous solution (PH 6,8) Example 2 Substitute for glycyrrhizin in Example 1 A concentrated solution (pH 5,62) of ammonium salt of glycyrrhizinate with a concentration of 20≦ as glycyrrhizin was obtained by the same method using monoammonium salt 20.49.
After adjusting the pH to 6.7 with sodium hydroxide,
diluted to give 0.0 oz as glycyrrhizin.
An aqueous solution (PH 6,8) of 25'≦ was obtained.

実施例3 実施例1におけるグリチルリチンの代りにモノカリウム
塩20.99を用い、同様の方法にょシグリチルリチン
として20%のグリチルリチン酸カリウム塩の濃厚溶液
(PH5,65)を得た。
Example 3 A 20% concentrated solution (pH 5,65) of potassium glycyrrhizinate was obtained as glycyrrhizin in the same manner as in Example 1, using 20.99% monopotassium salt instead of glycyrrhizin.

実施例4 クレアチニン20fを水100 ’にかくはん下に懸濁
しておき、これに室温(25℃)でグリチルリチン40
9を少しずつ加え、約3時間かくはんを続け、澄明なさ
らさらしたグリチルリチンの濃厚溶液(PH5,20)
を得た。
Example 4 Creatinine 20f was suspended in 100' of water while stirring, and glycyrrhizin 40f was added to this at room temperature (25°C).
Add 9 little by little and continue stirring for about 3 hours to obtain a clear and free-flowing concentrated solution of glycyrrhizin (PH5.20).
I got it.

この溶液をIN水酸化ナトリウムでPRを6.7に調整
した後、水で2tになるように希釈して2%のグリチル
リチン水溶液(pHs、s)を得だ。
After adjusting the PR of this solution to 6.7 with IN sodium hydroxide, it was diluted with water to 2t to obtain a 2% glycyrrhizin aqueous solution (pHs, s).

実施例5Example 5

Claims (1)

【特許請求の範囲】[Claims] グリチルリチンまたはそのモノ塩をクレアチニンの存在
下に室温で溶解することを特徴とするグリチルリチンま
たはそのモノ塩の濃厚水溶液の製造法。
1. A method for producing a concentrated aqueous solution of glycyrrhizin or a monosalt thereof, which comprises dissolving glycyrrhizin or a monosalt thereof in the presence of creatinine at room temperature.
JP16978385A 1985-08-02 1985-08-02 Production of concentrated aqueous solution of glycyrrhizin Pending JPS6230794A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16978385A JPS6230794A (en) 1985-08-02 1985-08-02 Production of concentrated aqueous solution of glycyrrhizin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16978385A JPS6230794A (en) 1985-08-02 1985-08-02 Production of concentrated aqueous solution of glycyrrhizin

Publications (1)

Publication Number Publication Date
JPS6230794A true JPS6230794A (en) 1987-02-09

Family

ID=15892787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16978385A Pending JPS6230794A (en) 1985-08-02 1985-08-02 Production of concentrated aqueous solution of glycyrrhizin

Country Status (1)

Country Link
JP (1) JPS6230794A (en)

Similar Documents

Publication Publication Date Title
IE43809L (en) Low fat spread
NO983320L (en) Melamine polymethaphosphate and process for its preparation
JP2602529B2 (en) Crystalline human proinsulin and method for producing the same
US4061720A (en) Preparation of ammonium and potassium zirconium carbonates
AU7054087A (en) Process for preparing high-purity dermatan sulphate, and pharmaceutical compositions which contain it
US20060069276A1 (en) Method of making iron(III)gluconate complex
US5466846A (en) Process for preparation of stable aqueous solutions of zirconium chelates
US2920014A (en) Insulin crystals and preparations and processes for producing them
FI956156A0 (en) Cyclodextrin inclusion complexes of SIN-1A
JPS6230794A (en) Production of concentrated aqueous solution of glycyrrhizin
CA2008068A1 (en) Bismuth-containing compositions suitable for therapeutic use
CN108892627A (en) The technique of one pot process taurine
US2692281A (en) Preparation of hydrazodicarbonamide
JPS6263597A (en) Prevention of sediment of aqueous ascorbic acid phosphate magnesium solution
CN111961102A (en) 5' -uridine monophosphate crystal and preparation method thereof
GB1480886A (en) Preparation of 2-deutero-3-fluoro alanine and its salts
JPS5865214A (en) Medicine containing n-acyl-l-aspartyltaurine
US3578656A (en) Method of making allantoin polygalacturonic acid compounds
SU1730110A1 (en) Method of producing bismuth oxychloride base mother-of-pearl pigment
CN103553952B (en) The recovery method of alpha-amino group-p-hydroxyphenylaceticacid in a kind of solution
Zittle et al. Influence of sodium chloride on the stability of the calcium caseinate micelle
JPS6259118B2 (en)
GB1384194A (en) Process for the production of trisodium or tripotassium citrate
US4007186A (en) Process for preparing uric acid
KR950010159B1 (en) Process for preparing water-soluble bismuth compound